Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
about
Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to BortezomibEnhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy.Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side ChainMultifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.Phosphate-Catalyzed Succinimide Formation from an NGR-Containing Cyclic Peptide: A Novel Mechanism for Deammoniation of the Tetrahedral Intermediate
P2860
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumor vascular targeted liposo ...... tivity in human neuroblastoma.
@en
type
label
Tumor vascular targeted liposo ...... tivity in human neuroblastoma.
@en
prefLabel
Tumor vascular targeted liposo ...... tivity in human neuroblastoma.
@en
P2093
P50
P1476
Tumor vascular targeted liposo ...... tivity in human neuroblastoma.
@en
P2093
Amelia Parise
Andrea Milelli
Chiara Brignole
Chiara Marchetti
Guendalina Zuccari
Laura Emionite
Michele Cilli
Vincenzo Tumiatti
Vito Pistoia
P356
10.1016/J.JCONREL.2015.05.286
P407
P50
P577
2015-05-29T00:00:00Z